Characterization and antimicrobial susceptibility of Clostridium difficile strains isolated from adult patients with diarrhoea hospitalized in two university hospitals in Poland, 2004–2006
Open Access
- 1 August 2011
- journal article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 60 (8) , 1200-1205
- https://doi.org/10.1099/jmm.0.029801-0
Abstract
This study analysed 330 Clostridium difficile strains isolated from patients with C. difficile infection who were hospitalized in two university hospitals (H1 and H2) in Warsaw, Poland, over the period 2004–2006. Strains were investigated for the presence of tcdA (A), tcdB (B) and binary toxin (CDT) genes, and antimicrobial susceptibility was determined against nine agents. Among the 330 C. difficile isolates, 150 (45.4 %) were classified as A+B+CDT−, 18 (5.5 %) as A+B+CDT+, 144 (43.6 %) as A−B+CDT− and 18 (5.5 %) as A−B−CDT−. The predominant PCR ribotype in hospitals H1 and H2 was type 017 and accounted for 48.3 and 40.0 %, respectively. Only one PCR ribotype 027 strain was found. The rates of resistance to erythromycin and clindamycin in hospitals H1 and H2 were 53.6 and 53.6 %, and 48.6 and 47.5 %, respectively, whereas resistance rates to the newer fluoroquinolones gatifloxacin and moxifloxacin were 38.5 and 38.5 % (H1) and 38.4 and 40.1 % (H2). Erythromycin resistance was frequently associated with resistance to clindamycin and newer fluoroquinolones in strains belonging to type 017. No metronidazole- and vancomycin-resistant isolates were found, although two C. difficile isolates had elevated MIC values of metronidazole (MIC range 1.0−1.5 mg l−1) and 15 strains revealed elevated MIC values for vancomycin (MIC range 1.5–2.0 mgl−1). In conclusion, an increase in non-027 CDT-producing C. difficile strains was observed in Poland, but C. difficile PCR ribotype 017 remains a major circulating type.Keywords
This publication has 22 references indexed in Scilit:
- Clostridium difficile Isolates Resistant to Fluoroquinolones in Italy: Emergence of PCR Ribotype 018Journal of Clinical Microbiology, 2010
- The Changing Epidemiology of Clostridium difficile InfectionsClinical Microbiology Reviews, 2010
- Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spreadThe Lancet Infectious Diseases, 2010
- Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, ArgentinaClinical Microbiology & Infection, 2009
- Clostridium difficile Toxin CDT Induces Formation of Microtubule-Based Protrusions and Increases Adherence of BacteriaPLoS Pathogens, 2009
- Emergence of reduced susceptibility to metronidazole in Clostridium difficileJournal of Antimicrobial Chemotherapy, 2008
- Toxin Profiles and Resistances to Macrolides and Newer Fluoroquinolones as Epidemicity Determinants of Clinical Isolates of Clostridium difficile from Warsaw, PolandJournal of Clinical Microbiology, 2007
- Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistanceJournal of Medical Microbiology, 2006
- Molecular Analysis of the Pathogenicity Locus and Polymorphism in the Putative Negative Regulator of Toxin Production (TcdC) among Clostridium difficile Clinical IsolatesJournal of Clinical Microbiology, 2002
- Epidemics of Diarrhea Caused by a Clindamycin-Resistant Strain ofClostridium difficilein Four HospitalsNew England Journal of Medicine, 1999